Efficacy of alprostadil in preventing contrast‐induced nephropathy in patients undergoing percutaneous coronary intervention: A multicenter prospective randomized controlled trial

Efficacy of alprostadil in preventing contrast‐induced nephropathy in patients undergoing... INTRODUCTIONContrast‐induced nephropathy (CIN), also known as contrast‐induced acute kidney injury (CIAKI), is a frequent complication after intravascular contrast media administration. It is defined as an increase in baseline serum creatinine (SCr) level by ≥ 25% or an absolute increase ≥ 44.2 umol/L within 48 or 72 hr after contrast media administration . The advanced development in the field of interventional cardiology resulted in an increasing number of CIN patients and CIN has become the third leading cause of hospital‐acquired acute kidney injury followed by surgical operation and nephrotoxic drug damage, accounting for 11% . However, the present guideline merely recommends the intravenous hydration, use of iso‐ or low‐osmolar contrast media, minimization of contrast volume to prevent the occurrence of CIN and none of other strategies were proved effective in preventing CIN . Therefore, effective strategies need to be explored to prevent the occurrence of CIN.Although the pathophysiological mechanisms of CIN are complex and uncertain, it may be associated with intense vasoconstriction mediated by endothelin, inhibition of nitric oxide‐mediated vasodilation, release of reactive oxygen species and direct toxic effects on tubular cells from contrast media, thus leading to ischemic injury of medulla outer area and the occurrence of CIN . In addition, the inadequate http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Catheterization and Cardiovascular Interventions Wiley

Efficacy of alprostadil in preventing contrast‐induced nephropathy in patients undergoing percutaneous coronary intervention: A multicenter prospective randomized controlled trial

Loading next page...
 
/lp/wiley/efficacy-of-alprostadil-in-preventing-contrast-induced-nephropathy-in-uMoA50p0Kw
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
© 2018 Wiley Periodicals, Inc.
ISSN
1522-1946
eISSN
1522-726X
D.O.I.
10.1002/ccd.27353
Publisher site
See Article on Publisher Site

Abstract

INTRODUCTIONContrast‐induced nephropathy (CIN), also known as contrast‐induced acute kidney injury (CIAKI), is a frequent complication after intravascular contrast media administration. It is defined as an increase in baseline serum creatinine (SCr) level by ≥ 25% or an absolute increase ≥ 44.2 umol/L within 48 or 72 hr after contrast media administration . The advanced development in the field of interventional cardiology resulted in an increasing number of CIN patients and CIN has become the third leading cause of hospital‐acquired acute kidney injury followed by surgical operation and nephrotoxic drug damage, accounting for 11% . However, the present guideline merely recommends the intravenous hydration, use of iso‐ or low‐osmolar contrast media, minimization of contrast volume to prevent the occurrence of CIN and none of other strategies were proved effective in preventing CIN . Therefore, effective strategies need to be explored to prevent the occurrence of CIN.Although the pathophysiological mechanisms of CIN are complex and uncertain, it may be associated with intense vasoconstriction mediated by endothelin, inhibition of nitric oxide‐mediated vasodilation, release of reactive oxygen species and direct toxic effects on tubular cells from contrast media, thus leading to ischemic injury of medulla outer area and the occurrence of CIN . In addition, the inadequate

Journal

Catheterization and Cardiovascular InterventionsWiley

Published: Jan 1, 2018

Keywords: ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial